Key Takeaways
- Congress passed H.R. 6500, which delays the hemp ban until December 11, 2026, pending President Trump’s signature.
- The delay covers most hemp-derived products like delta-8 and CBD but excludes synthetic cannabinoids, which still face a November 12 deadline.
- The hemp market is substantial, estimated at $28 billion, but 95% of current products may not meet the new definition once it takes effect.
- Trump supports the hemp ban delay and is likely to sign H.R. 6500, influenced by public and industry pressure.
- Businesses should prepare for the upcoming deadline by knowing THC limits and confirming product types before the regulations change.
The waiting game is nearly over. For months, the hemp industry watched Congress debate whether to push back a federal ban that would reshape the entire market. That debate is settled. Both chambers have passed the stopgap spending measure containing the hemp provision, and the only step left is a signature from President Donald Trump.
What Did Congress Just Do With H.R. 6500?
On September 1, 2026, the U.S. House passed a short-term government funding bill in a 370-48 vote. The Senate had already approved the same measure 90-6 last month.
Tucked inside that continuing resolution is the hemp provision. It funds the federal government through December 11, 2026, and moves the hemp ban’s effective date to that same day.
The bill now sits on the president’s desk. Until he signs it, November 12 remains the legal deadline. Once he does, the clock resets to December 11.
What Does the Hemp Ban Delay Actually Cover?
The delay applies to most plant-derived hemp cannabinoid products. That includes delta-8, delta-9, CBD, and full-spectrum items derived from the cannabis plant.
Under the law Trump signed in November 2025, hemp was redefined to allow only products containing 0.4 milligrams or less of total THC per container. That threshold is far below the 2018 Farm Bill standard, which permitted hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis. If H.R. 6500 becomes law, that new definition stays paused for qualifying products until December 11.
The stakes are large. Industry groups estimate the hemp-derived cannabinoid market at roughly $28 billion in annual value, supporting more than 300,000 jobs. Analysts have warned that around 95% of current hemp products could fall outside the new definition once it takes effect.
Which Hemp Products Are Not Protected by the Delay?
Here is the catch that matters most for certain operators. The delay does not treat all hemp products equally.
Synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant” still face recriminalization on November 12, regardless of what Trump signs. That carve-out is written directly into the bill.
If your product relies on cannabinoids with no natural analog in the cannabis plant, the December 11 date does not apply to you. Those products hit the original November 12 deadline. Businesses built around fully synthetic compounds should not read this delay as protection.
Why Is Trump Expected to Sign H.R. 6500?
The president has been one of the loudest voices calling for a hemp fix, which is why a signature looks likely.
In an April 2026 Truth Social post, Trump wrote, “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on.” He added, “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously.”
His administration reinforced that stance in the weeks that followed. As we detailed in Trump Pushes Federal Hemp Ban Delay Amid White House Drama, the White House Office of Management and Budget pressed House Speaker Mike Johnson in June to “ensure the fair treatment of hemp products.” Trump also personally called Sen. Ted Budd (R-NC), who had filed an amendment to strip the delay. The Senate later killed that amendment 61-32.
The White House has said its advisers would recommend the president sign. Sen. Amy Klobuchar (D-MN), who authored the delay provision, urged that “the President should sign this bipartisan bill into law immediately.”
What Happens After December 11, 2026?
The delay buys time, not certainty. When government funding expires December 11, the hemp question returns with it.
That gives Congress another window to attach a longer-term fix to a must-pass spending package. Several proposals are already circulating. Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN) introduced a bipartisan bill to prevent recriminalization while building a regulatory framework covering manufacturing, labeling, sales, taxation, and a minimum purchase age of 21. Rep. James Comer (R-KY) is circulating a separate measure with packaging requirements, testing rules, and age limits. A Senate companion from Sens. Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) is expected as well.
None of those bills have cleared committee. So while the industry has a reprieve, the fight over permanent rules is still very much open.
What This Means for Hemp Businesses Right Now
Two clocks are running. The hard November 12 date still governs synthetic products and remains the operative deadline until Trump signs. For everyone else selling qualifying plant-derived products, a signature moves the line to December 11.
Not everyone is celebrating. A bipartisan coalition of 35 state attorneys general urged Congress to reject the delay, arguing the November 2025 redefinition “protected consumers, provided much-needed regulatory clarity, and preserved legitimate industrial, agricultural, and nonintoxicating hemp markets.” We broke that down in 35 Attorneys General Unite to Urge Congress to Maintain the Upcoming Federal Hemp Ban.
Jonathan Miller, general counsel for the U.S. Hemp Roundtable, called the outcome a “lifeline of a 30-day extension,” while Jim Higdon of Cornbread Hemp cautioned that “one month is not much time.”
What Should Hemp Businesses Do Before the Deadline?
A month is short, but it is enough to make decisions with real consequences. A few steps hold no matter how Congress acts in December:
- Know your numbers. Total THC, including THCa and delta-8, is the federal measure, and 0.4 milligrams per container is the finished-product line.
- Confirm your product type. Plant-derived products get the delay. Synthetic cannabinoids do not.
- Watch your payment rail. Some processors have moved to cut hemp and CBD ahead of either federal date, which could arrive before Congress reconvenes.
- Keep records tight. Certificates of analysis, formulation records, and labeling decisions are what a business leans on when a standard tightens.
The industry is no longer debating whether Congress might preserve the delay. Congress did. Now the decisions shift back to operators and to a December deadline that will test whether a one-month reprieve turns into something more lasting.
Frequently Asked Questions
Under current law, the federal hemp ban takes effect November 12, 2026. If President Trump signs H.R. 6500, most of the new restrictions move to December 11, 2026. Until he signs, November 12 stands.
Trump is expected to sign H.R. 6500. He has publicly urged Congress to fix the hemp law since April 2026, and the White House has said its advisers would recommend he sign the bill.
H.R. 6500 is the stopgap continuing resolution that funds the federal government through December 11, 2026. It contains the provision delaying most of the new federal hemp restrictions to that same date.
Yes, for now. The new federal definition has not taken effect and is not retroactive. Plant-derived products such as CBD, delta-8, and full-spectrum items would keep their current status until the deadline. State rules may be stricter and can arrive sooner.
Synthetic cannabinoids that the cannabis plant cannot naturally produce are excluded. Those products still face recriminalization on November 12, 2026, regardless of the signing.
The November 2025 law redefined hemp to allow only finished products containing 0.4 milligrams or less of total THC per container. It is a per-container cap, not a percentage, and it is one of the most consequential figures in the law.
